Directors

Tan Sri Datuk Seri Panglima Sulong was appointed to the Board of Directors (“Board”) on 6 August 2014 and subsequently appointed as Independent Non-Executive Chairman on 15 July 2015. He was appointed as a member of the Nomination & Remuneration Committee on 27 February 2018 and was a member of the Audit Committee from 26 November 2020 to 29 February 2024.

Other than SAB, he is currently also an Independent Non-Executive Chairman of Petra Energy Berhad and WTK Holdings Berhad. He is also the Chairman of the Board of Directors of University of Malaysia, Sarawak and the Chairman of the Board of Guardians of Sarawak Sovereign Wealth Future Fund.

Tan Sri Sulong, who has more than thirty (30) years of legal and judicial experience, was a Federal Court Judge before his retirement in 2013.

He was one of the four eminent persons appointed by the Prime Minister of Malaysia to serve in the Judicial Appointments Commission for two terms. His first term began on 10 February 2013 to 9 February 2015 and his second term was from 10 February 2016 to 9 February 2017.

Tan Sri Sulong is a Bencher of the prestigious Honorable Society of Inner Temple, London and his education background is as follows:-

Dr. Nick Low was appointed to the Board on 15 July 2015.

He holds a Diploma in Medical Sciences from International Medical University, a MBA from Open University Malaysia and a Bachelor of Medicine & Bachelor of Surgery from The University of Auckland, New Zealand.

From 2012 to 2015, Dr. Nick Low was involved in the strategic management of an oil palm plantation development project with its grounds in the province of Kalimantan Timur, Indonesia. Dr. Nick Low is a director of the oleochemical making and tertiary healthcare hospital operating subsidiaries of SAB. He is also a board member of the two Indonesian incorporated estates and palm oil mill operating subsidiaries of SAB. Additionally, Dr. Nick Low is a director of Kumpulan Klinik Medijaya Sdn Bhd with its small chain of owned and managed primary health care (general practice) clinics.

Datuk Wira Lim was appointed to the Board on 10 August 2005 and was redesignated as an Executive Director on 28 August 2008.

He pursued his pre-university education at Kolej Tunku Abdul Rahman, Kuala Lumpur. He is actively involved in the corporate affairs and general management of Southern Acids (M) Berhad and its subsidiaries, especially in the area of oil palm plantation and employee relations.

Mr. Chung was appointed to the Board on 20 March 2012 and subsequently appointed as the Senior Independent Non-Executive Director on 25 July 2013 until he was re-designated to Non-Independent Non-Executive Director on 20 March 2024. Following his redesignation, he was also redesignated as a member of the Audit Committee on 29 February 2024 but remain as the Chairman of the Nomination & Remuneration Committee on 26 November 2013.

He holds a Bachelor of Business (Accounting) from the Phillip Institute of Technology, Australia and is a fellow member of Certified Practising Accountant Australia. He has over twenty (20) years of experience in merchant banking, corporate finance, accounting and general management. Prior to the appointment to the Board, Mr Chung was the Group Chief Financial Officer of Zelan Berhad.

Mr. Stephen Wan was appointed to the Board on 27 March 2023. He was appointed as a member of the Audit Committee on 26 May 2023, and subsequently appointed as the Chairman on 29 February 2024. He was also appointed as a member of the Nomination & Remuneration Committee on 26 May 2023. He is currently also the Independent Non-Executive Director of HCK Capital Group Berhad.

He is a member of the Malaysian Institute of Accountants ("MIA") and member of The Malaysian Institute of Certified Public Accountants.

Mr. Stephen Wan is an approved Company Auditor and is currently the Managing Partner of Moore Stephens Associates PLT, an independent member firm of Moore Global Network Limited. He has also been appointed by the MIA to be a member of the Capital Market Advisory Committee that serve as a liaison between the MIA, regulators and key stakeholders on capital market related matters.

Mr. Stephen Wan has twenty-five (25) years of professional experience which includes more than twenty (20) years of experience in Big Four Accounting Firms. He has professional experience in valuation of shares, and business of companies for purposes of takeover, merger and restructuring exercises, initial public offerings and due diligence. In addition, his experience includes audit and assurance for various listed companies, property development and construction, manufacturing, cement production, trading, publishing, industrial engineering, textile, hotel, investment holding, forwarding agencies, plantation and operational headquarters.

Madam Debbie was appointed to the Board on 30 August 2023 and subsequently appointed as a member of the Audit Committee on 29 February 2024.

She obtained her Bachelor of Laws (Hons) from the University of Leicester and was called to the Bar of England and Wales by the Honourable Society of Lincoln’s Inn.

Madam Debbie started her career as a lawyer, for the first three years in litigation followed by sixteen (16) years in the corporate field. As a partner in a boutique leading law firm, her areas of practice extended to cover corporate finance, capital markets (Islamic and conventional), mergers & acquisitions, debt restructuring, general corporate and commercial.

From 2015 until early 2022, she was part of the founding team of Projek57, an award-winning accredited social enterprise which aspires to influence youths from multicultural backgrounds with nation building values, as well as empower the underprivileged.

Since April 2022, she rejoined legal practice as the Chief Operating Officer of the law firm of Adnan Sundra & Low where she is able to combine her legal experience with management. She also focuses on exploring ways to enhance the practice of the firm including enhancing efficiency and overall capability and formulating their business strategies.